Residents who were physically restrained daily during the 7-day assessment period
-
Percentage of residents on most recent assessments who were physically restrained daily during the 7-day assessment period
CBE ID0193
Percentage of residents on most recent assessments who were physically restrained daily during the 7-day assessment period
Percentage of residents with a valid target and a valid prior assessment whose need for more help with daily activities has increased
Percentage of residents with a valid target assessment and a valid prior assessment, with a decline in their ability to move about in their room and the adjacent corridor.
Percentage of residents on most recent assessment with a urinary tract infection
Percentage of esidents with a valid target assessment and a valid prior assessment with worsening of a depressed or anxious mood.
Total number of patients that have vest and/or limb restraint (upper or lower body or both) on the day of the prevalence measurement episode.
The number of hospital discharges with a retained surgical item or unretrieved device fragment (secondary diagnosis) among surgical and medical patients ages 17 years and younger. Excludes normal newborns, newborns with birth weight less than 500 grams, cases with principal diagnosis of retained surgical item or unretrieved device fragment, cases with a secondary diagnosis of retained surgical item or unretrieved device fragment present on admission, and obstetric cases.
The number of hospital discharges with a retained surgical item or unretrieved device fragment (secondary diagnosis) among surgical and medical patients ages 18 years and older or obstetric patients. Excludes cases with principal diagnosis of retained surgical item or unretrieved device fragment and cases with a secondary diagnosis of retained surgical item or unretrieved device fragment present on admission.
Periodic clinical review of unplanned readmissions to the PICU that occurred within 24 hours of discharge or transfer from the PICU.
Percent of Rh negative pregnant women at risk of fetal blood exposure who receive Rhogam the ED.